Skip to content
healthcare.dev

Abiraterone

NDC 82009-139, Abiraterone acetate, tablet, from Quallent Pharmaceuticals Health LLC.

Product NDC
82009-139
Status
Listed
Labeler
Quallent Pharmaceuticals Health LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210686
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82009-139 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ABIRATERONE ACETATE250 mg/1

Pharmacologic classes

Cytochrome P450 17A1 Inhibitor [EPC]; Cytochrome P450 17A1 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]

Package NDCNDC-11Package
82009-139-1282009013912120 TABLET in 1 BOTTLE (82009-139-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6f5b628b-69da-4a04-a4d5-623b18d1fd5d
  • NADAC price for package 82009013912

    GET /v1/drugs/nadac/82009013912

Use it

Look up 82009-139 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82009-139 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82009-139. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.